Merck’s Covid pill Molnupiravir was authorized for the first time in the U.K.
among those who received the drug was 7.3% compared to 14.1% of those given a placebo, Merck said.
Merck said it expects global revenue from the pill, developed by it and Ridgeback Biotherapeutics, to total up toAt home, whether the pill will receive the green light will be determined when the Food and Drug Administration meets to discuss the safety and efficacy data of molnupiravir at the end of this month.Professor Sir Munir Pirmohamed, chair of the U.K.’s Commission on Human Medicines said that Lagevrio—monulpiravir's brand name in the U.K.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Merck’s Covid Pill Molnupiravir Authorized For First Time In The U.K.In the U.S., the Food and Drug is slated to convene on November 30 to decide whether to green light the oral pill for emergency use after examining the safety and efficacy data of the pill.
Read more »
‘Covid breakthrough’: Pfizer says new drug could nearly end Covid deathsAccording to Pfizer, clinical trials show their new anti-viral drug cuts the risk of death and hospitalization in high-risk adults by 89%.
Read more »
'I barely function some days': Covid 'long haulers' struggle to work amid labor shortageLast November, Laurie Bedell and her family contracted Covid-19. The virus killed her father. She's still battling post-Covid syndrome, a mysterious long-term condition plaguing some coronavirus patients, and she remains so ill she's unable to work.
Read more »
Britain becomes the first nation to authorize Merck's COVID-19 pillBritain's conditional authorization of Merck’s COVID-19 treatment pill gives the country another weapon in the fight against the pandemic.
Read more »
New CDC Covid-19 Warnings: Avoid Travel To Russia, Belgium, Slovakia, Burkina FasoAdditionally, Poland went from moderate to high Covid-19 risk. But situations in Fiji and Jamaica have improved.
Read more »